Labo Euromedis (LTS:0I0L) ROCE % : -22.38% (As of Jun. 2023)

View and export this data going back to 2018. Start your Free Trial

What is Labo Euromedis ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Labo Euromedis's annualized ROCE % for the quarter that ended in Jun. 2023 was -22.38%.

Labo Euromedis ROCE % Historical Data

The historical data trend for Labo Euromedis's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Labo Euromedis ROCE % Chart

Labo Euromedis Annual Data

Trend

Jul13

Jul14

Jul15

Jul16

Jul17

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

-10.79

70.41

4.84

-10.30

50.22

Labo Euromedis Semi-Annual Data
	Jul13	Jan14	Jul14	Jan15	Jul15	Jan16	Jul16	Jan17	Jul17	Jan18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
ROCE %	Get a 7-Day Free Trial															-9.09	-21.00	0.80	-22.38	132.96

Labo Euromedis ROCE % Calculation

Labo Euromedis's annualized ROCE % for the fiscal year that ended in Dec. 2022 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2022 )		(A: Dec. 2021 )		(A: Dec. 2022 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2022 )		(A: Dec. 2021 )		(A: Dec. 2022 )
	=	-5.631	/	( ( (72.722 - 13.663)	+	(59.868 - 9.545) )	/ 2 )
	=	-5.631	/	( (59.059	+	50.323)	/ 2 )
	=	-5.631	/	54.691
	=	-10.30 %

Labo Euromedis's ROCE % of for the quarter that ended in Jun. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Jun. 2023 )		(Q: Dec. 2022 )		(Q: Jun. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Jun. 2023 )		(Q: Dec. 2022 )		(Q: Jun. 2023 )
	=	-10.654	/	( ( (59.868 - 9.545)	+	(54.675 - 9.769) )	/ 2 )
	=	-10.654	/	( ( 50.323	+	44.906 )	/ 2 )
	=	-10.654	/	47.6145
	=	-22.38 %

(1) Note: The EBIT data used here is two times the semi-annual (Jun. 2023) EBIT data.

Labo Euromedis (LTS:0I0L) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Labo Euromedis ROCE % Related Terms

Thank you for viewing the detailed overview of Labo Euromedis's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Labo Euromedis (LTS:0I0L) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Labo Euromedis (LTS:0I0L) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

ALEMG:France 61R:Germany

Address

ZI de la Tuilerie, Neuilly-sous-Clermont, FRA, 60290

Website

https://www.euromedis.fr

Euromedis Groupe is engaged in medical devices. It is engaged in the design, manufacture, rental and export of medical and surgical equipment and products.

Labo Euromedis (LTS:0I0L) Headlines

No Headlines